BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 28221062)

  • 41. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder.
    Fortuna LR; Porche MV; Padilla A
    Psychol Psychother; 2018 Mar; 91(1):42-62. PubMed ID: 28815876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
    Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
    J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adults with Comorbid Posttraumatic Stress Disorder, Alcohol Use Disorder, and Opioid Use Disorder: The Effectiveness of Modified Prolonged Exposure.
    Peck KR; Schumacher JA; Stasiewicz PR; Coffey SF
    J Trauma Stress; 2018 Jun; 31(3):373-382. PubMed ID: 29786898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Group-delivered cognitive/exposure therapy for PTSD in women veterans: A randomized controlled trial.
    Castillo DT; Chee CL; Nason E; Keller J; C'de Baca J; Qualls C; Fallon SK; Haaland KY; Miller MW; Keane TM
    Psychol Trauma; 2016 May; 8(3):404-412. PubMed ID: 26854355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emotion dysregulation moderates the effect of cognitive behavior therapy with prolonged exposure for co-occurring PTSD and substance use disorders.
    Hien DA; Lopez-Castro T; Papini S; Gorman B; Ruglass LM
    J Anxiety Disord; 2017 Dec; 52():53-61. PubMed ID: 29049902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trauma- and Stress-Induced Response in Veterans with Alcohol Dependence and Comorbid Post-Traumatic Stress Disorder.
    Ralevski E; Southwick S; Jackson E; Jane JS; Russo M; Petrakis I
    Alcohol Clin Exp Res; 2016 Aug; 40(8):1752-60. PubMed ID: 27368085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl.
    Tuerk PW; Wangelin BC; Powers MB; Smits JAJ; Acierno R; Myers US; Orr SP; Foa EB; Hamner MB
    Cogn Behav Ther; 2018 Sep; 47(5):351-371. PubMed ID: 29448886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emotional Processing of Imaginal Exposures Predicts Symptom Improvement: Therapist Ratings Can Assess Trajectory in Prolonged Exposure for Posttraumatic Stress Disorder.
    Cox KS; Wangelin BC; Keller SM; Lozano BE; Murphy MM; Maher EK; Cobb AR; Tuerk PW
    J Trauma Stress; 2020 Jun; 33(3):338-344. PubMed ID: 32103546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparing Exposure- and Coping Skills-Based Treatments on Trauma-Related Guilt in Veterans With Co-Occurring Alcohol Use and Posttraumatic Stress Disorders.
    Capone C; Tripp JC; Trim RS; Davis BC; Haller M; Norman SB
    J Trauma Stress; 2020 Aug; 33(4):603-609. PubMed ID: 32521096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using the research domain criteria framework to track domains of change in comorbid PTSD and SUD.
    Zambrano-Vazquez L; Levy HC; Belleau EL; Dworkin ER; Howard Sharp KM; Pittenger SL; Schumacher JA; Coffey SF
    Psychol Trauma; 2017 Nov; 9(6):679-687. PubMed ID: 28165268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PTSD Avoidance Symptoms Associated With Alcohol Craving in Treatment-Seeking Veteran Population.
    Flynn AJ; Navarro GY; Basehore HK
    J Dual Diagn; 2022; 18(3):135-143. PubMed ID: 35761472
    [No Abstract]   [Full Text] [Related]  

  • 52. Integrated Cognitive Behavioral Therapy Versus Cognitive Processing Therapy for Adults With Depression, Substance Use Disorder, and Trauma.
    Haller M; Norman SB; Cummins K; Trim RS; Xu X; Cui R; Allard CB; Brown SA; Tate SR
    J Subst Abuse Treat; 2016 Mar; 62():38-48. PubMed ID: 26718130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
    Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
    Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Residual Symptoms of Posttraumatic Stress Disorder and Alcohol Use Disorder Following Integrated Exposure Treatment Versus Coping Skills Treatment.
    Tripp JC; Angkaw A; Schnurr PP; Trim RS; Haller M; Davis BC; Norman SB
    J Trauma Stress; 2020 Aug; 33(4):477-487. PubMed ID: 32557843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Affective lability predicts decreased habituation in posttraumatic stress symptom responding during a single laboratory session of imaginal exposure.
    Dutton CE; Badour CL; Jones AC; Mischel ER; Feldner MT
    J Anxiety Disord; 2016 Oct; 43():52-57. PubMed ID: 27517669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder: results from a department of veterans affairs cooperative study.
    Schnurr PP; Friedman MJ; Foy DW; Shea MT; Hsieh FY; Lavori PW; Glynn SM; Wattenberg M; Bernardy NC
    Arch Gen Psychiatry; 2003 May; 60(5):481-9. PubMed ID: 12742869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice.
    Somohano VC; Rehder KL; Dingle T; Shank T; Bowen S
    J Dual Diagn; 2019; 15(4):233-242. PubMed ID: 31304887
    [No Abstract]   [Full Text] [Related]  

  • 58. Distress tolerance: Associations with trauma and substance cue reactivity in low-income, inner-city adults with substance use disorders and posttraumatic stress.
    Vujanovic AA; Wardle MC; Bakhshaie J; Smith LJ; Green CE; Lane SD; Schmitz JM
    Psychol Addict Behav; 2018 May; 32(3):264-276. PubMed ID: 29771557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal Sequencing of Change in Posttraumatic Cognitions and PTSD Symptom Reduction During Prolonged Exposure Therapy.
    Kumpula MJ; Pentel KZ; Foa EB; LeBlanc NJ; Bui E; McSweeney LB; Knowles K; Bosley H; Simon NM; Rauch SA
    Behav Ther; 2017 Mar; 48(2):156-165. PubMed ID: 28270327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence.
    McLean CP; Su YJ; Foa EB
    J Consult Clin Psychol; 2015 Jun; 83(3):655-61. PubMed ID: 26009787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.